Abiopharma

New Form SCHEDULE 13G/A - OppFi Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003579 <b>Size:</b> 7 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001918704-26-023766 <b>Size:</b> 523 KB

New Form 424B2 - Marex Group Ltd <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-096657 <b>Size:</b> 1 MB

Mandatory Cash Dividend/ Distribution:

Financial Statements and Related Announcement: Half Yearly Results

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000950103-26-012382 <b>Size:</b> 257 KB

New Form SCHEDULE 13G - FibroBiologics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003577 <b>Size:</b> 10 KB

(30% Negative) NEUMORA THERAPEUTICS, INC. (NMRA) Reports Q3 2026 Financial Results

New Form SCHEDULE 13G/A - Evogene Ltd. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003576 <b>Size:</b> 10 KB

New Form SCHEDULE 13G - Praetorian Acquisition Corp. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003575 <b>Size:</b> 7 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001918704-26-023765 <b>Size:</b> 968 KB

New Form SCHEDULE 13G - Collective Acquisition Corp. II <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003574 <b>Size:</b> 7 KB

New Form SCHEDULE 13G/A - Estrella Immunopharma, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003573 <b>Size:</b> 10 KB

New Form SCHEDULE 13G - Enveric Biosciences, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003572 <b>Size:</b> 10 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000950103-26-012381 <b>Size:</b> 254 KB